Seizert Capital Partners, LLC Merck & Co., Inc. Transaction History

Seizert Capital Partners, LLC

$2.16 Billion
Q3 2024

A detailed history of Seizert Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 3,720 shares of MRK stock, worth $368,949. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,720

Previous 3,720 -0.0%

Holding current value

$368,949

Previous $460,000 8.26%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $18,373 - $20,390	-256 Reduced 6.44%	3,720 $304,000
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $605,658 - $839,471	-9,559 Reduced 70.62%	3,976 $306,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $77,347 - $87,277	-997 Reduced 6.86%	13,535 $1.23 Million
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $21,378 - $23,303	-281 Reduced 1.9%	14,532 $1.22 Million
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $288,299 - $336,803	-4,128 Reduced 21.79%	14,813 $1.24 Million
Q1 2019 May 07, 2019	SELL	$69.58 - $79.36 $63,456 - $72,376	-912 Reduced 4.59%	18,941 $1.58 Million
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $15,266 - $17,716	-234 Reduced 1.16%	19,853 $1.52 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $950,615 - $1.12 Million	-16,478 Reduced 45.06%	20,087 $1.43 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $114,660 - $133,267	-2,250 Reduced 5.8%	36,565 $1.99 Million
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $42,173 - $50,359	-817 Reduced 2.06%	38,815 $2.18 Million
Q3 2017 Oct 31, 2017	SELL	$58.67 - $63.13 $539,587 - $580,606	-9,197 Reduced 18.84%	39,632 $2.54 Million
Q2 2017 Aug 09, 2017	BUY	N/A	48,829	48,829 $3.13 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Merck & Co., Inc. Transaction History